1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Cordis Medical Device Company Intelligence Report

Cordis Medical Device Company Intelligence Report

  • July 2013
  • -
  • Espicom Business Intelligence
  • -
  • 34 pages

Based in New Jersey in the US, Cordis develops and manufactures medical devices for the treatment of vascular disease, and through its Biosense Webster subsidiary, provides cardiac diagnostic, therapeutic and mapping tools. At the time of its formation in 1957, the company was called Medical Development Corporation; its name was changed in 1959 to Cordis (“of the heart”) to reflect its primary therapeutic focus.

Cordis now focuses on access, diagnostic and therapeutic products for cardiology procedures, products to diagnose, access and treat lower extremity disease, and the Incraft stent-graft system, the company’s new investigational device for treating abdominal aortic aneurysm (AAA). The company is also offers globally ExoSeal, its first vascular closure device.

The Cordis Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.

Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.


Key Benefits

Evaluate competitive threats
Maximise product and market opportunities
Identify collaborators and strategic partners
Understand the operating market environment
Benchmark your performance against competitors

Coverage Overview

Key contact information
Introduction to Cordis and its current activities
Summary of its financial performance
Key recent events in an “at a glance” format

Strategic Focus

The company’s aims and its areas of focus

Financial Review

Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Product Overview

Core product areas, key brands, product approvals and launches
Identifies the company’s major competitors

Research and Development

How much has been invested in R&D?
Where is the research based?
What alliances and agreements does Cordis have and with whom?

Manufacturing and Distribution

Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements

With whom has Cordis reached agreements and what do they involve?
Key contracts awarded
Mergers and Acquisitions


Minority Investments

Divestitures

Litigation

Key Corporate Events


Table Of Contents

Cordis Medical Device Company Intelligence Report
Contents

OVERVIEW 1

STRATEGIC FOCUS 3
Espicom View 3

FINANCIAL REVIEW 4
2012 Financial Results 4
Employees 6

PRODUCTS 7
Cordis 7
Stents 7
Vascular Closure 8
Biosense Webster 11
Biologics Delivery Systems 16

RESEARCH AND DEVELOPMENT 17
Research Establishments 17
Studies and Trials 18
Cordis 18
ExoSeal Vascular Closure Devices 18
INNOVATION Trial - Incraft Stent Graft System 18
STROLL Trial 19
SAPPHIRE 20
Biosense Webster 20
ATTEST Study 20
SMART-AF Study 20
reMARQable 21
RAAFT 21
Research Agreements 22
Stereotaxis 22
Medtronic 22

MANUFACTURING 23

AGREEMENTS 24
Siemens Healthcare 24
GE Healthcare 24
Stereotaxis 25
Ostial Solutions 26
ClearStream Technologies 26
Svelte Medical Systems 26

MERGERS AND ACQUISITIONS 27
Flexible Stenting Solutions 27
Ensure Medical 28
LuMend 28
TERAMed 28
Atrionix 28
AngioGuard 29
IsoStent 29
Biosense 29
Nitinol Devices and Components 29

DIVESTITURES 30
Cordis Neurovascular Division 30
Nitinol Devices and Components 30
Cordis Neuroscience Business 30

LITIGATION 31
Guidant, Abbott, Boston Scientific and Medtronic - Morris Patents 31
Boston Scientific - Fischell Patent 31
Guidant, Abbott, Boston Scientific and Medtronic - Wright/Falotico Patents 31
Boston Scientific - Jang Patent 31
Dr Bruce Saffran 32

KEY CORPORATE EVENTS 33



List of Tables

Recent Key Events 2
Cordis - Annual Sales, 2008-2012 4
Cordis/Biosense Webster - Summary of Recent Product Approvals and Selected Planned Submissions as of January 2013 15
Agreements Summary 23
Mergers and Acquisitions Summary 26
Cordis - Key Corporate Events 32



List of Charts

Johnson and Johnson - Medical Devices and Diagnostics Segment - 2012 Sales by Major Franchise 4
Cordis - Annual Sales, 2008-2012 5
Cordis - Annual Sales by Geographic Area, 2008-2012 5

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.